Skip to main content
. 2022 Aug 19;11(16):4874. doi: 10.3390/jcm11164874

Figure 1.

Figure 1

The survival time of hepatocellular carcinoma patients receiving combination therapy. (PFS, progress free survival; OS, overall survival).